Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-07-11 Sale |
2022-07-11 4:09 pm |
Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew Chief of Pharma Sciences & MFG |
150,000 | $0 | $0 | 0 (Direct) |
View |
| 2021-10-19 Sale |
2021-10-20 4:05 pm |
Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew See Remarks |
3,759 | $3.19 | $11,991 | 46,241 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-05-20 Tax Withholding |
2024-05-21 8:15 pm |
N/A N/A |
Innoviva Inc. | INVA | Ronsheim Matthew See Remarks |
268 | $16.13 | 40,510 (Direct) |
View |
| 2024-03-05 Option Award |
2024-03-07 7:02 pm |
2025-02-20 2034-03-05 |
Innoviva Inc. | INVA | Ronsheim Matthew See Remarks |
27,338 | $0 | 161,216 (Direct) |
View |
| 2024-03-05 Option Award |
2024-03-07 7:02 pm |
N/A N/A |
Innoviva Inc. | INVA | Ronsheim Matthew See Remarks |
12,768 | $14.88 | 161,216 (Direct) |
View |
| 2024-02-20 Tax Withholding |
2024-02-22 9:31 pm |
N/A N/A |
Innoviva Inc. | INVA | Ronsheim Matthew See Remarks |
807 | $15.8 | 28,010 (Direct) |
View |
| 2024-01-18 Option Award |
2024-01-22 9:16 pm |
2025-02-20 2034-01-17 |
Innoviva Inc. | INVA | Ronsheim Matthew See Remarks |
60,000 | $0 | 121,917 (Direct) |
View |
| 2024-01-18 Tax Withholding |
2024-01-22 9:16 pm |
N/A N/A |
Innoviva Inc. | INVA | Ronsheim Matthew See Remarks |
1,600 | $16.05 | 121,917 (Direct) |
View |
Ownership |
2024-01-10 8:26 pm |
N/A N/A |
Innoviva Inc. | INVA | Ronsheim Matthew See Remarks |
0 | $0 | 63,517 (Direct) |
View |
| 2022-07-07 Equity Swap |
2022-07-11 4:09 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew Chief of Pharma Sciences & MFG |
17,572 | $2.2 | 0 (Direct) |
View |
| 2022-07-11 Other |
2022-07-11 4:09 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew Chief of Pharma Sciences & MFG |
88,333 | $0 | 0 (Direct) |
View |
| 2021-07-16 Option Award |
2022-02-15 4:04 pm |
N/A 2031-07-15 |
Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew See Remarks |
33,333 | $0 | 33,333 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-19 4:04 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew See Remarks |
125,000 | $0 | 167,572 (Direct) |
View |
| 2021-11-02 Tax Withholding |
2021-11-03 4:05 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew Chief, Pharma Sciences & MFG. |
3,669 | $2.94 | 42,572 (Direct) |
View |
| 2021-10-19 Option Award |
2021-10-20 4:05 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew See Remarks |
25,000 | $0 | 46,241 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-19 4:09 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew See Remarks |
25,000 | $0 | 25,000 (Direct) |
View |
Ownership |
2020-09-11 4:33 pm |
N/A 2029-09-16 |
Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew See Remarks |
0 | $0 | 95,000 (Direct) |
View |